Abdullaev SP

References (4)

Title : Clinically relevant pharmacogenetic markers in Tatars and Balkars - Abdullaev_2020_Mol.Biol.Rep_47_3377
Author(s) : Abdullaev SP , Mirzaev KB , Burashnikova IS , Shikaleva AA , Kachanova AA , Akmalova KA , Sozaeva ZA , Grishina EA , Sozaeva MS , Rytkin EI , Sychev DA
Ref : Mol Biol Rep , 47 :3377 , 2020
Abstract :
PubMedSearch : Abdullaev_2020_Mol.Biol.Rep_47_3377
PubMedID: 32303955

Title : Effects of the rs2244613 polymorphism of the CES1 gene on the antiplatelet effect of the receptor P2Y12 blocker clopidogrel - Mirzaev_2019_Drug.Metab.Pers.Ther_34_
Author(s) : Mirzaev KB , Osipova DV , Kitaeva EJ , Shprakh VV , Abdullaev SP , Andreev DA , Mumladze RB , Sychev DA
Ref : Drug Metab Pers Ther , 34 : , 2019
Abstract :
PubMedSearch : Mirzaev_2019_Drug.Metab.Pers.Ther_34_
PubMedID: 31560647

Title : [Comparative clinical and economic evaluation of pharmacogenetic testing application for dabigatran in patients with atrial fibrillation] - Abdullaev_2019_Ter.Arkh_91_22
Author(s) : Abdullaev SP , Mirzaev KB , Sychev DA
Ref : Ter Arkh , 91 :22 , 2019
Abstract :
PubMedSearch : Abdullaev_2019_Ter.Arkh_91_22
PubMedID: 32598750

Title : Genetic determinants of dabigatran safety (CES1 gene rs2244613 polymorphism) in the Russian population: multi-ethnic analysis - Sychev_2019_Mol.Biol.Rep_46_2761
Author(s) : Sychev DA , Abdullaev SP , Mirzaev KB , Ryzhikova KA , Shuyev GN , Sozaeva ZA , Grishina EA , Mammaev SN , Gafurov DM , Kitaeva EY , Shprakh VV , Suleymanov SS , Bolieva LZ , Sozaeva MS , Zhuchkova SM , Gimaldinova NE , Sidukova EE , Asoskova AV , Mumladze RB
Ref : Mol Biol Rep , 46 :2761 , 2019
Abstract :
PubMedSearch : Sychev_2019_Mol.Biol.Rep_46_2761
PubMedID: 30850966
Gene_locus related to this paper: human-CES1